Quoin Pharmaceuticals (QNRX) Net Cash Flow (2021 - 2026)

Quoin Pharmaceuticals has disclosed Net Cash Flow across 6 years of filings, most recently posting $721506.0 for Q2 2026.

• In Q2 2026, Net Cash Flow rose 133.5% year-over-year to $721506.0; the TTM figure through Jun 2026 stood at $2.2 million (up 285.08% YoY), while the FY2025 annual figure was $195366.0, down 84.01% from the prior year.
• Net Cash Flow came in at $721506.0 for Q2 2026 at Quoin Pharmaceuticals, up from -$694027.0 in the prior quarter.
• In the past five years, Net Cash Flow ranged from a high of $2.6 million in Q3 2022 to a low of -$2.5 million in Q2 2022.
• Average Net Cash Flow over 5 years is -$202032.5, with a median of $180596.5 recorded in 2025.
• Year-over-year, Net Cash Flow jumped 339.93% in 2022 and slumped 449.15% in 2026.
• Over 5 years, Net Cash Flow stood at -$2.4 million in 2022, then soared by 68.1% to -$762228.0 in 2023, then soared by 166.46% to $506593.0 in 2024, then soared by 292.39% to $2.0 million in 2025, then sank by 63.7% to $721506.0 in 2026.
• Per Business Quant data, the three most recent Net Cash Flow figures were $721506.0 in Q2 2026, -$694027.0 in Q1 2026, and $2.0 million in Q4 2025.